© 2024 Western New York Public Broadcasting Association

140 Lower Terrace
Buffalo, NY 14202

Mailing Address:
Horizons Plaza P.O. Box 1263
Buffalo, NY 14240-1263

Buffalo Toronto Public Media | Phone 716-845-7000
WBFO Newsroom | Phone: 716-845-7040
Your NPR Station
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

UB restarts clinical trials, as coronavirus lessens

University at Buffalo

One of the core areas of medical research at the University at Buffalo's Medical School is restarting this week, after being quiescent for more than three months because of COVID-19.

Clinical trials are a key element in medical research, so restarting them is a big deal. Clinical trials are often the first chance for doctors to see if new drugs or treatments can deal with serious health problems.

On average, UB is doing 200 clinical trials with 3,000 patients at any one time, with the trial often offering the last chance of a patient for life. It is also an economic opportunity locally, since many of these trials are conducted by researchers who are starting companies to use the research.

Pulmonologist Dr. Sanjay Sethi is a prominent UB researcher and Clinical Research Office director.

                 17000    :              ...stop that

Sethi does COVID-19 research. His work and that of others on the virus has continued all during the crisis. But leading edge work on hepatitis, diabetes and heart valves has stalled during the national quarantine.

It isn’t just the doctors. There are hordes of graduate students, young doctors, medical students and others who are building their careers in these fields, only to see everything stop.

Mike Desmond is one of Western New York’s most experienced reporters, having spent nearly a half-century covering the region for newspapers, television stations and public radio. He has been with WBFO and its predecessor, WNED-AM, since 1988. As a reporter for WBFO, he has covered literally thousands of stories involving education, science, business, the environment and many other issues. Mike has been a long-time theater reviewer for a variety of publications and was formerly a part-time reporter for The New York Times.
Related Content